1. Home
  2. PODD vs NTAP Comparison

PODD vs NTAP Comparison

Compare PODD & NTAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • NTAP
  • Stock Information
  • Founded
  • PODD 2000
  • NTAP 1992
  • Country
  • PODD United States
  • NTAP United States
  • Employees
  • PODD N/A
  • NTAP N/A
  • Industry
  • PODD Medical/Dental Instruments
  • NTAP Electronic Components
  • Sector
  • PODD Health Care
  • NTAP Technology
  • Exchange
  • PODD Nasdaq
  • NTAP Nasdaq
  • Market Cap
  • PODD 23.8B
  • NTAP 23.7B
  • IPO Year
  • PODD 2007
  • NTAP 1995
  • Fundamental
  • Price
  • PODD $340.29
  • NTAP $124.16
  • Analyst Decision
  • PODD Strong Buy
  • NTAP Buy
  • Analyst Count
  • PODD 18
  • NTAP 16
  • Target Price
  • PODD $334.50
  • NTAP $123.00
  • AVG Volume (30 Days)
  • PODD 532.2K
  • NTAP 2.2M
  • Earning Date
  • PODD 11-06-2025
  • NTAP 08-27-2025
  • Dividend Yield
  • PODD N/A
  • NTAP 1.67%
  • EPS Growth
  • PODD N/A
  • NTAP 10.60
  • EPS
  • PODD 3.32
  • NTAP 5.66
  • Revenue
  • PODD $2,359,500,000.00
  • NTAP $6,590,000,000.00
  • Revenue This Year
  • PODD $29.18
  • NTAP $4.98
  • Revenue Next Year
  • PODD $18.09
  • NTAP $5.07
  • P/E Ratio
  • PODD $102.63
  • NTAP $22.05
  • Revenue Growth
  • PODD 26.00
  • NTAP 3.34
  • 52 Week Low
  • PODD $225.37
  • NTAP $71.84
  • 52 Week High
  • PODD $353.50
  • NTAP $135.45
  • Technical
  • Relative Strength Index (RSI)
  • PODD 59.53
  • NTAP 72.51
  • Support Level
  • PODD $336.00
  • NTAP $122.58
  • Resistance Level
  • PODD $351.94
  • NTAP $125.63
  • Average True Range (ATR)
  • PODD 8.16
  • NTAP 3.39
  • MACD
  • PODD -1.50
  • NTAP 0.80
  • Stochastic Oscillator
  • PODD 46.37
  • NTAP 90.35

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About NTAP NetApp Inc.

NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of the cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services. Geographically, the company generates the majority of its revenue from the United States, Canada and Latin America (Americas).

Share on Social Networks: